Corvascular Overview

  • Founded

  • 1997

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 25

Employees
  • Latest Deal Type

  • M&A

Corvascular General Information

Description

Provider of technology for minimally invasive cardiac surgery. The company is the developer of the Transarrest platform, which enables surgeons to temporarily stop a patient's heart in order to place sutures on the coronary arteries.

Contact Information

Website
www.corvascular.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Acquirer
Medtronic
Primary Office
  • 490 San Antonia Road
  • Palo Alto, CA 94306
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Corvascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 0000 Completed Product Development
2. Early Stage VC (Series B) 01-Oct-1998 000 0000 0000 Completed Product Development
1. Early Stage VC (Series A) 06-May-1997 $3M $3M 000.00 Completed Startup
To view Corvascular’s complete valuation and funding history, request access »

Corvascular Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.0 00.0 00.0 00.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Corvascular’s complete cap table history, request access »

Corvascular Patents

  • 8

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Corvascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D440304-S1 Direct fluid-delivery system Inactive 27-Oct-1999
AU-7368700-A Bifurcated shunt drug delivery system and methods of use Inactive 09-Sep-1999 000000000000
AU-6402300-A Direct injection fluid delivery device and method Inactive 03-Jun-1999 00000000000
AU-2188700-A Intravascular cardiac assist device and method Inactive 15-Dec-1998 0000000000
AU-1917900-A Fluid delivery apparatus and methods Inactive 19-Nov-1998 A61M25/0041
To view Corvascular’s complete patent history, request access »

Corvascular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Corvascular Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Apax Partners PE/Buyout Minority 000 0000 000000 0
Atherton Venture Partners Venture Capital Minority 000 0000 000000 0
Brentwood Venture Capital Venture Capital Minority 000 0000 000000 0
Delphi Ventures Venture Capital Minority 000 0000 000000 0
To view Corvascular’s complete investors history, request access »

Ready to get started?

Request a free trial